✦ LIBER ✦
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching
✍ Scribed by I. Le Ray; S. Dabakuyo; G. Crehange; M. Bardou; L. Arnould; J. Fraisse; P. Fumoleau; B. Coudert; S. Causeret; P. Arveux; P. Maingon; F. Bonnetain
- Book ID
- 116431104
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 496 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.